26/03/2014 - 15:25
Olokizumab, a humanized monoclonal antibody specific for the interleukin-6 cytokine, showed promise for patients with rheumatoid arthritis who had an inadequate response to antitumor necrosis factor...
Field of Interest: Rheumatology
Categories:
News Feed: Internal Medicine News - Rheumatology